It appears from the above findings that memantine, an NMDA receptor antagonist, has a positive effect on cognition in patients with vascular dementia.

20 мар. 2019 г. · Memantine has a small beneficial effect in people with moderate-to-severe AD. This benefit affects thinking, the ability to carry on normal daily activities.

1 июл. 2002 г. · Conclusions— In patients with mild to moderate vascular dementia, memantine 20 mg/d improved cognition consistently across different cognitive ...

Memantine has not been approved for vascular dementia or earlier stages of AD in any jurisdiction. Memantine is marketed as Axura by Merz, as Ebixa by Lundbeck ...

Memantine is a dementia drug that is only recommended for people with Alzheimer's. Slowing down the progression of vascular dementia. Although there is no ...

6 июн. 2023 г. · All four drugs are safe for patients with vascular dementia, but their effects are very limited. Memantine is globally recognized for its ...

Cholinesterase inhibitors and memantine do not have regulatory approval in most of the world for treatment of vascular dementia. A systematic review and ...

16 июл. 2024 г. · Conclusion: Memantine appeared to be beneficial in improving BPSD in VaD patients and demonstrated a good safety profile. There is currently ...

Alzheimer's disease medicines, such as donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) or memantine are not used to treat vascular dementia, ...

The cognitive benefit by memantine treatment was larger for the small vessel group and, interestingly, also the decline in the placebo group was faster in the ...